
Asarfi Hospital Ltd Downgraded to Hold Amid Mixed Technical Signals and Valuation Assessment
2026-05-20 08:31:02Asarfi Hospital Ltd, a micro-cap player in the hospital sector, has seen its investment rating downgraded from Buy to Hold as of 19 May 2026. The revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust financial performance and market-beating returns, evolving technical indicators and valuation metrics have prompted a more cautious stance.
Read MoreAsarfi Hospital Ltd Surges 17.15% in a Week: Key Financials and Technicals Drive Momentum
2026-05-09 11:00:05Key Events This Week 4 May: Week opens at Rs.215.80 5 May: Downgrade to Buy amid mixed technical and valuation signals 6 May: New 52-week high at Rs.246 and all-time high at Rs.238 7 May: New 52-week high at Rs.254 and all-time high at Rs.251; upgrade to Strong Buy 8 May: Week closes at Rs.252.80 (+3.18%) Week OpenRs.215.80 <d...
Read More
170% Stock Return vs 161% Profit Growth: What Drives Asarfi Hospital Ltd’s Multibagger Rally?
2026-05-07 10:05:04A 170.47% stock return in one year. A 161% growth in net profit over the same period. The gap between those two numbers — roughly 9 percentage points — reflects a market that has largely rewarded Asarfi Hospital Ltd for its earnings growth rather than multiple expansion. This close alignment between returns and fundamentals is the key to understanding the stock’s recent performance.
Read More
Asarfi Hospital Ltd Hits All-Time High of Rs 251 as Momentum Builds Across Timeframes
2026-05-07 09:37:13Extending a three-day winning streak, Asarfi Hospital Ltd surged to a fresh all-time high of Rs 251 on 7 May 2026, outperforming its sector and the broader market with a 2.64% gain on the day.
Read More
Asarfi Hospital Ltd Upgraded to Strong Buy on Robust Financials and Technical Momentum
2026-05-07 08:33:17Asarfi Hospital Ltd has been upgraded from a Buy to a Strong Buy rating by MarketsMOJO as of 6 May 2026, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The micro-cap hospital sector stock has demonstrated exceptional performance, outpacing benchmarks and signalling strong investor confidence.
Read More
Broad-Based Technical Strength Lifts Asarfi Hospital Ltd to 52-Week High of Rs 246
2026-05-06 12:40:20Surging to an all-time high of Rs 246 on 6 Jun 2026, Asarfi Hospital Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 166.67% gain over the past year. This milestone caps a sustained rally fuelled by strong technical signals and robust financial performance.
Read More
Asarfi Hospital Ltd Downgraded to Buy Amid Mixed Technical and Valuation Signals
2026-05-05 09:07:57Asarfi Hospital Ltd’s investment rating has been revised from Strong Buy to Buy, reflecting nuanced changes across technical indicators, valuation metrics, financial trends, and quality assessments. Despite robust financial performance and market-beating returns, evolving technical signals and valuation considerations have prompted a more cautious stance from analysts.
Read MoreAsarfi Hospital Ltd Falls 3.50%: 4 Key Events Shaping This Week’s Decline
2026-04-25 11:00:04Key Events This Week 20 Apr: Stock opens at Rs.219.45 with a 1.62% gain 21 Apr: New 52-week high and all-time high reached near Rs.226.7 22 Apr: Further 52-week and all-time high at Rs.231 amid strong momentum 23-24 Apr: Sharp declines with heavy volume, closing week at Rs.208.40 Week OpenRs.219.45 Week Close<div clas...
Read MoreStatement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Issue.
30-May-2026 | Source : BSEWe wish you to inform you for the year ended March 31 2026 There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each aggregating to Rs.269360000/-issued by the company for the object stated in the offer document.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
30-May-2026 | Source : BSEWe hereby submit the transcript of the earning conference call held on May 27 2026 wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ended March 31 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
27-May-2026 | Source : BSEPursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation of our intimation dated May 21 2026 regarding the schedule of the Institutional Investor/Analyst Meet we hereby inform you that the Company participated in an Investor Meet (one-to-one meeting) organized by Chorus Call Conferencing Services (I) Pvt. Ltd. on May 27 2026 through a virtual platform.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
